It is the entire gene row of women suffering from breast cancer

Saints' Sequencing data can turn the way in the way clinic lessons trained and done, recommending the size of new weight

This is how the whole genetic order benefit women with breast cancer

The complete genome sequence can change the recruited and clinical experiments procedures, which ensures the development of new treatments

Inability to adapt to watching breast cancer in Andalusia is returning 2012, though on screen

This feature is only for registered users

Login using the most egg patients with the most egg patients, recognizing relief qualities, so guiding over 15,000 wives per year.

In 2022, 2.3 million women suffered from breast cancer and breast cancer, and the death tied of deaths.In recent years, the progress of the growth is still difficult to identify the best cures and the worst predictions and events.

The entire genome sequence is a strong technique that includes analysis of the patient's DNA and tumor to find genetic changes or mutations.This provides information about the underlying cause of the tumor and its causes.It is resistant to a particular treatment.

However, this technology is not always available to all types of medical services or all cancers.

Although it can be used, the Cabine University is the University of Cabine (UK, ", which does not apply to its full potential and especially in some of the most common cancer species.

The reasons are added: "This is the lack of clinical studies to support the use, but they are very rich because they are so rich that they can be very large."

To address this problem, Nik-Rainal has reviewed information from 2500 people in the UK.

The people who have 27% of the types of breast fees in the patients of the patients of the patients or services.

The analysis also provided information on prognosis.For example, more often with the hypothesis of breast cancer ER+HER2-Cark of Breast, which is about 70% of diagnoses, severe genetic percentages of aggression of cancer were observed.

Using this finding the researchers created a framework to help doctors identify which patients need more aggressive treatment. And which patients would be less likely to be treated safely, they also suggest that the estimated 7,500 women a year with low-grade tumors would benefit from more aggressive treatment.

Added to the use of seeing individuals of the patients, and complete data -based data -following data that may change in poverty.

This feature is reserved for subscribers

This feature is only intended for registered users

Solfer Allocation Only Without Friends